← Leaderboards
Joseph Rocco Bertino
Sloan-Kettering Institute For Cancer Res
$26,398,552
Attributed
$26,398,552
Total exposure
16
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5.4M · FY2005–16$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$30,013,071 · 18
By mechanism
P30$25,335,302 · 11
R01$3,278,563 · 2
P01$1,130,528 · 4
K12$268,678 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Institute For Cancer Res
Same institution · by research overlap
- David R Spriggs$13,987,182
- Jon Scott Thorson$24,592,329
- Jason A Koutcher$20,695,436
- Michel Sadelain$9,562,550
- Riccardo Dalla-Favera$29,692,137
Others in their field
Top investigators on “Cancer Center Support Grant”
- David Heimbrook · Leidos Biomedical Research, Inc.$253,882,416
- Mary L. Disis · University Of Washington$91,856,641
- Julianne L Imperato-McGinley · Weill Medical College Of Cornell Univ$87,214,340
- Jeffrey S Flier · Beth Israel Deaconess Medical Center$79,061,055
- Robert J Gray · Dana-Farber Cancer Institute$78,329,401
- Eric S Lander · Whitehead Institute For Biomedical Res$71,530,862
Research focus
Cancer Center Support GrantCancer Institute Of New JerseyResource SharingProgramsLeadershipPopulation SciencesServicesComprehensive Cancer CenterLaboratoriesProstateInstitutesBasic ScienceDihydrofolate ReductaseClinical SciencesPreventionNeoplasm /Cancer PharmacologyTranslational ResearchInstructionFundingHealth SciencesThymidylate SynthaseMedical OncologyMentorshipPositioning Attribute
Grant awards (67)
SENIOR LEADERSHIP$2,415,701
P30 · FY2016 · CA · contact PI
SENIOR LEADERSHIP$1,472,956
P30 · FY2015 · CA · contact PI
SENIOR LEADERSHIP$1,472,951
P30 · FY2015 · CA · contact PI
SENIOR LEADERSHIP$1,474,987
P30 · FY2014 · CA · contact PI
SENIOR LEADERSHIP$1,383,785
P30 · FY2014 · CA · contact PI
SENIOR LEADERSHIP$2,116,924
P30 · FY2013 · CA · contact PI
SENIOR LEADERSHIP$663,836
P30 · FY2013 · CA · contact PI
SENIOR LEADERSHIP$124,999
P30 · FY2013 · CA · contact PI
SENIOR LEADERSHIP$111,497
P30 · FY2013 · CA · contact PI
SENIOR LEADERSHIP$49,999
P30 · FY2013 · CA · contact PI
SENIOR LEADERSHIP$31,250
P30 · FY2013 · CA · contact PI
SENIOR LEADERSHIP$1
P30 · FY2013 · CA · contact PI
Collaborative Projects component$905,784
P30 · FY2012 · CA · contact PI
SENIOR LEADERSHIP$840,645
P30 · FY2012 · CA · contact PI
DEVELOPMENTAL FUNDS$757,561
P30 · FY2012 · CA · contact PI
PLANNING AND EVALUATION$497,689
P30 · FY2012 · CA · contact PI
Collaborative Projects component$139,119
P30 · FY2012 · CA · contact PI
PLANNING AND EVALUATION$100,117
P30 · FY2012 · CA · contact PI
PLANNING AND EVALUATION$74,529
P30 · FY2012 · CA · contact PI
Collaborative Projects component$50,641
P30 · FY2012 · CA · contact PI
DEVELOPMENTAL FUNDS$1,447,727
P30 · FY2009 · CA · contact PI
SENIOR LEADERSHIP$1,110,838
P30 · FY2009 · CA · contact PI
PROGRAM LEADERS$645,415
P30 · FY2009 · CA · contact PI
PLANNING AND EVALUATION$201,008
P30 · FY2009 · CA · contact PI
DEVELOPMENTAL FUNDS$362,344
P30 · FY2008 · CA · contact PI
Mechanism of Action of Folate Antagonist$331,745
R01 · FY2008 · CA · contact PI
SENIOR LEADERSHIP$278,027
P30 · FY2008 · CA · contact PI
PROGRAM LEADERS$161,538
P30 · FY2008 · CA · contact PI
Mechanism of Action of Folate Antagonist$70,077
R01 · FY2008 · CA · contact PI
PLANNING AND EVALUATION$50,312
P30 · FY2008 · CA · contact PI
Cancer Center Support Grant$3,128,377
P30 · FY2007 · CA · contact PI
OFFICE OF HUMAN RESEARCH SERVICES$454,625
P30 · FY2007 · CA · contact PI
DEVELOPMENTAL FUNDS$376,237
P30 · FY2007 · CA · contact PI
Mechanism of Action of Folate Antagonist$331,745
R01 · FY2007 · CA · contact PI
SENIOR LEADERSHIP$288,688
P30 · FY2007 · CA · contact PI
ADMINISTRATIVE CORE$191,965
P30 · FY2007 · CA · contact PI
PROGRAM LEADERS$167,729
P30 · FY2007 · CA · contact PI
Cancer Center Support Grant$127,296
P30 · FY2007 · CA · contact PI
Cancer Center Support Grant$108,846
P30 · FY2007 · CA · contact PI
Mechanism of Action of Folate Antagonist$65,018
R01 · FY2007 · CA · contact PI
DATA AND SAFETY MONITORING$58,288
P30 · FY2007 · CA · contact PI
PLANNING AND EVALUATION$52,235
P30 · FY2007 · CA · contact PI
Mechanism of Action of Folate Antagonist$341,654
R01 · FY2006 · CA · contact PI
Mechanism of Action of Folate Antagonist$349,875
R01 · FY2005 · CA
Mechanism of Action of Folate Antagonist$349,875
R01 · FY2004 · CA
MECHANISM OF ACTION OF FOLATE ANTAGONISTS$316,416
R01 · FY2003 · CA
MECHANISM OF ACTION OF FOLATE ANTAGONISTS$313,937
R01 · FY2002 · CA
MECHANISMS OF DRUG RESISTANCE IN SOFT TISSUE SARCOMA$230,631
P01 · FY2002 · CA
MOLECULAR PHARMACOLOGY AND THERAPEUTICS$157,506
P30 · FY2002 · CA
CORE--ANALYTICAL PHARMACOLOGY$157,506
P30 · FY2002 · CA
MODIFIED HEMATOPOIETIC STEM CELLS FOR AUTOGRAFTING$0
P01 · FY2002 · CA
MECHANISM OF ACTION OF FOLATE ANTAGONISTS$310,048
R01 · FY2001 · CA
MECHANISMS OF DRUG RESISTANCE IN SOFT TISSUE SARCOMA$230,631
P01 · FY2001 · CA
CORE--ANALYTICAL PHARMACOLOGY$157,506
P30 · FY2001 · CA
MOLECULAR PHARMACOLOGY AND THERAPEUTICS$157,506
P30 · FY2001 · CA
MODIFIED HEMATOPOIETIC STEM CELLS FOR AUTOGRAFTING$0
P01 · FY2001 · CA
MECHANISM OF ACTION OF FOLATE ANTAGONISTS$302,269
R01 · FY2000 · CA
CLINICAL AND MOLECULAR CANCER RESEARCH TRAINING PROGRAM$268,678
K12 · FY2000 · CA
CANCER CHEMOTHERAPY PROGRAM PROJECT$250,000
P01 · FY2000 · CA
CORE--ANALYTICAL PHARMACOLOGY$246,900
P30 · FY2000 · CA
MOLECULAR PHARMACOLOGY AND THERAPEUTICS$246,900
P30 · FY2000 · CA
MECHANISMS OF DRUG RESISTANCE IN SOFT TISSUE SARCOMA$230,631
P01 · FY2000 · CA
NEW THERAPIES FOR HEPATIC METASTASIS FROM COLON CANCER$195,904
R01 · FY2000 · CA
CORE--PHARMACOLOGY CORE$188,635
P01 · FY2000 · CA
MOLECULAR PHARMACOLOGY AND THERAPEUTICS$157,506
P30 · FY2000 · CA
CORE--ANALYTICAL PHARMACOLOGY$157,506
P30 · FY2000 · CA
MODIFIED HEMATOPOIETIC STEM CELLS FOR AUTOGRAFTING$0
P01 · FY2000 · CA